Wang Xiaodong

CIK: 0001662982

Wang Xiaodong is a corporate insider at BeOne Medicines Ltd. (ONC) filing SEC Form 4 transactions. 325 transactions, totaling $0 in purchases and $140,327,655 in sales. Source: SEC EDGAR.

AI Insider Summary

Wang Xiaodong (CIK 0001662982, 325 transactions) has one of the most structurally informative Form 4 files in the dataset: two nearly identical 542,880-share option exercises on BeiGene Ltd. (BGNE/ONC) at a $6.50 strike — first in May 2025 and again in June 2025 — while the ADR traded in the $220–$265 range, producing an in-the-money spread of roughly $140M–$145M per exercise. In each case he sold only a fraction of the exercised shares (≤42,000 shares at $222–$225 in May; ≤22,000 shares at $261–$265 in June), retaining the bulk of the exercised block. Across 2025 he then made two large gifts (code 'G') of 424,073 shares (November 2025) and 148,096 shares (September 2025) — totaling 572,169 shares of ONC with no disclosed price, consistent with a family-wealth or charitable distribution. Lifetime ONC sell aggregate of 872,654 shares against zero buys is misleadingly skewed by the option exercises (which inflate the buy count when processed) and the gifts; the honest read is an executive who has exercised deeply, gifted meaningfully, and retained most of his exposure rather than liquidating it.

Wang's Form 4 file contains two near-identical option-exercise events: May 13, 2025 and June 10, 2025, both for 542,880 shares of BeiGene at a $6.50 strike price. On the May date the underlying BGNE ADR traded around $222–$225; on the June date the ONC-linked shares traded around $261–$265. At those prices, the in-the-money spread per exercise is on the order of $140M–$145M, making these two of the largest single-event option exercises visible in the Form 4 universe. The paired 'M' entries on BGNE (May 13, June 10) and the corresponding ONC failures-to-deliver/settlement entries suggest a single stock option exercised against two listings — the economic event is one exercise, the filing system records it twice.

He sold only a fraction of what he exercised.

Analysis generated by 13F Insight from SEC Form 4 filing data. Methodology
Total Transactions
325
Total Buy Value
$0
Total Sell Value
$140.33M
Net Activity
$-140.33M
Last Transaction
Jun 2026
Companies
1

Companies

Transaction History

Source: SEC EDGAR Form 4 insider transaction filings.

Type
Award
Shares
193,492
Price
$20.81
Value
$4.03M
Type
Award
Shares
99,892
Price
-
Value
-
Type
Gift
Shares
424,073
Price
-
Value
-
Type
Gift
Shares
148,096
Price
-
Value
-
Type
Sale
Shares
100
Price
$267.81
Value
$27K
Type
Sale
Shares
507
Price
$266.57
Value
$135K
Type
Sale
Shares
1,100
Price
$265.35
Value
$292K
Type
Sale
Shares
300
Price
$263.50
Value
$79K
Type
Exercise
Shares
542,880
Price
-
Value
-
Type
Award
Shares
185,796
Price
-
Value
-
Type
Sale
Shares
100
Price
$264.85
Value
$26K
Type
Sale
Shares
6,787
Price
$264.08
Value
$1.79M
Type
Sale
Shares
16,094
Price
$263.17
Value
$4.24M
Type
Sale
Shares
15,878
Price
$262.20
Value
$4.16M
Type
Sale
Shares
2,901
Price
$261.20
Value
$758K
Type
Exercise
Shares
41,760
Price
$6.50
Value
$271K
Type
Award
Shares
98,696
Price
-
Value
-
BeiGene, Ltd.
BGNE
Type
Exercise
Shares
542,880
Price
-
Value
-
BeiGene, Ltd.
BGNE
Type
Sale
Shares
200
Price
$225.68
Value
$45K
BeiGene, Ltd.
BGNE
Type
Sale
Shares
10,104
Price
$224.32
Value
$2.27M